Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Year: 2021
Type: conference-abstract
Source: Blood
Institution: University of Illinois Chicago
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3213386299
